Quality of Life in Normogonadotropic Anovulation

Status Recruiting

Clinical Trial Summary

Among the causes of ovulation disorders (group II of anovulation according to the World Health Organization classification), the dominant one is polycystic ovary syndrome (PCOS), and the remaining cases are classified as Hypothalamic-Pituitary-Ovarian Axis Dysfunction (HPOD). The exact etiology of both entities is unknown. To diagnose PCOS, the Rotterdam criteria must be met and other conditions that may cause hyperandrogenism or ovulation disorders must be excluded. PCOS is more often accompanied by other endocrine and metabolic disorders, such as obesity, dyslipidemia, hyperandrogenism, insulin resistance, diabetes, hyperprolactinemia and thyroid diseases, as well as infertility due to ovulation defect. These conditions not only significantly reduce quality of life (QoL), but also lead to an increased risk of cardiovascular disease, metabolic syndrome, adverse obstetric outcomes and an increased risk of endometrial cancer, further impairing QoL.

Clinical Trial Description

A prospective questionnaire study will be conducted regarding the quality of life among women undergoing hormonal diagnostics due to anovulation. The study will include women aged 18-45 with ovulation disorders: PCOS (arm 1) and HPOD (arm 2). The quality of life will be assessed using the self-assessment method using the SF-36 questionnaire (Short Form Health Survey). The questionnaire is intended for a subjective assessment of health status. It consists of 11 questions containing 36 statements that allow you to determine eight quality of life indicators, i.e.: physical functioning, role limitations due to physical health, role limitations due to emotional problems, energy/fatigue, emotional well-being, social functioning, pain, general health, health change. The percentage score on a scale of 0-100% in each of the 8 life domains will be compared between both arms of the study. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06208995
Study type	Observational
Source	Jagiellonian University
Contact	Iwona Gawron, PhD, MD
Phone	+48 12 4248551
Email	iwona.gawron@uj.edu.pl
Status	Recruiting
Phase
Start date	July 1, 2023
Completion date	December 30, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01653743` - Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women	Phase 3
Completed	`NCT00327366` - Effect of Bright Light on Sex Hormones and Ovulation in Humans	N/A
Not yet recruiting	`NCT02551367` - Letrozole Versus Clomiphene Citrate for Ovulation Induction in Women With Poly Cystic Ovary Syndrome ( PCOS )	Phase 2
Completed	`NCT01923194` - Evaluation of Efficacy and Safety of Highly Purified Urofollitropin for Ovulation Induction in Chinese Females	Phase 3
Completed	`NCT01008319` - Traditional Clomiphene Citrate Administration vs. Stair-step Approach	Phase 3
Completed	`NCT00239603` - Efficacy Study of the OV-Watch™ Personal Fertility Monitor for Women Using Clomiphene Citrate.	Phase 4
Recruiting	`NCT02309047` - The Cycle Disturbances, OLigomenorrhea and Amenorrhea (COLA) Study & Biobank
Completed	`NCT03252223` - Ovarian Response to Recombinant Follicle Stimulating Hormone in Women With PCOS	Phase 4
Completed	`NCT00492882` - Study of Mechanisms of Anovulation in Polycystic Ovary Syndrome	Phase 4
Completed	`NCT02335879` - Phase III Clinical Study of Domestic Recombinant Human Follitropin for Injection to Treat WHO Class II Anovulation	Phase 3
Completed	`NCT00471523` - Treatment of Anovulatory Infertility in PCOS Patients	Phase 4
Completed	`NCT02703649` - Administration of Single High Dose Letrozole for Ovulation Induction	Phase 4
Completed	`NCT00213148` - Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction	Phase 2
Completed	`NCT03018314` - Serum Kisspeptin Levels in Infertile Women	N/A
Completed	`NCT02710981` - Sildenafil Vaginal Gel Co-treatment With Clomiphene Citrate in Infertile Women With Thin Endometrium	N/A
Recruiting	`NCT02186782` - Concomitant CC and E2 Versus CC Alone in Ovulation Induction	Phase 4
Not yet recruiting	`NCT00665171` - Whole Genome Analysis for the Detection of Key Genes in the Polycystic Ovary Syndrome	N/A
Withdrawn	`NCT03155828` - Using CPAP to Improve Menstruation in Women With Polycystic Ovarian Syndrome and Obstructive Sleep Apnea
Withdrawn	`NCT00453219` - FHA: Characterization of Metabolic Status, Brain Circuitry, and Stress-Reactivity	N/A
Completed	`NCT00920634` - Protocol for Drug Use Investigation of Follistim Injection (Study P06132)(COMPLETED)